港股異動 | JS環球生活(1691.HK)續升超5% 6日累漲近20% 股價有望挑戰前高
格隆匯10月22日丨JS環球生活(1691.HK)連續反彈,6日累升近20%。現報16.72港元,漲5.16%,暫成交4969萬港元,總市值583.4億港元。前期創下新高18港元后開始回調,近幾日股價再起升勢有望挑戰前高。展望今年下半年,瑞銀認為公司加快新產品週期、產品擴張及國際市場擴張等,預計有助於帶動可持續增長,加上公司在創新產品上有競爭優勢,擁有全渠道的能力與價值等,均有助其搶佔國際市場份額,將該公司2020至2022年盈利預測提升3%。重申買入評級,目標價升至18.8港元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.